Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Oncology Institute (TOI) Depreciation & Amortization - Total (2021 - 2025)

Oncology Institute (TOI) has disclosed Depreciation & Amortization - Total for 5 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization - Total rose 25.75% year-over-year to $1.0 million, compared with a TTM value of $4.0 million through Sep 2025, up 29.73%, and an annual FY2024 reading of $3.2 million, up 11.45% over the prior year.
  • Depreciation & Amortization - Total was $1.0 million for Q3 2025 at Oncology Institute, down from $1.0 million in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $1.0 million in Q2 2025 and bottomed at $165000.0 in Q1 2021.
  • Average Depreciation & Amortization - Total over 5 years is $602947.4, with a median of $601000.0 recorded in 2023.
  • The sharpest move saw Depreciation & Amortization - Total soared 132.57% in 2023, then dropped 12.47% in 2024.
  • Year by year, Depreciation & Amortization - Total stood at $263000.0 in 2021, then soared by 74.9% to $460000.0 in 2022, then soared by 75.65% to $808000.0 in 2023, then increased by 15.35% to $932000.0 in 2024, then rose by 7.94% to $1.0 million in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for TOI at $1.0 million in Q3 2025, $1.0 million in Q2 2025, and $1.0 million in Q1 2025.